We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest News
NIH Launches Knockout Mouse Project
News

NIH Launches Knockout Mouse Project

Genome-Wide public resource will provide mouse models for understanding human disease.
Invitrogen Acquires Fluo 3 and Fluo 4 Product Lines from TEF Labs
News

Invitrogen Acquires Fluo 3 and Fluo 4 Product Lines from TEF Labs

Products to be manufactured and sold through Invitrogen's molecular probes business.
NIH Selects Regeneron for Knockout Mouse Project
News

NIH Selects Regeneron for Knockout Mouse Project

Regeneron will use its VelociGene® technology to target 3,500 genes over five years, providing models of human diseases.
LSGPA Invests $250,000 in SoftGenetics
News

LSGPA Invests $250,000 in SoftGenetics

SoftGenetics is helping translate the human genome into personalized medicine.
Dyax and Serono Announces Agreements for Discovery of Therapeutic Antibodies
News

Dyax and Serono Announces Agreements for Discovery of Therapeutic Antibodies

Dyax will perform funded research on certain targets of Serono to identify therapeutic antibodies.
Federal Microarray Quality Control Study Addresses Intercompatibility of Microarray Gene Expression Platforms
News

Federal Microarray Quality Control Study Addresses Intercompatibility of Microarray Gene Expression Platforms

Results pave the way for researchers to choose platform based on performance, value and quality of content.
BaroFold Grants Protein Technology Research License to Genentech
News

BaroFold Grants Protein Technology Research License to Genentech

The license agreement enables Genentech to utilize BaroFold's patented technology and instrumentation for research.
Partners HealthCare and Affymetrix Collaborate to Develop Microarray Diagnostics
News

Partners HealthCare and Affymetrix Collaborate to Develop Microarray Diagnostics

Research team to create and validate genetic tests based on Affymetrix GeneChip® Technology in CLIA Laboratories.
Strategic Diagnostics Announces Agreement to Supply Diagnostic Antibody Reagents
News

Strategic Diagnostics Announces Agreement to Supply Diagnostic Antibody Reagents

Strategic Diagnostics will begin shipping bio-reagents to the customer in the fourth quarter of 2006.
MBI Secures License to 'Microscale-on-Chip Valve' Technology from the UC Berkeley
News

MBI Secures License to 'Microscale-on-Chip Valve' Technology from the UC Berkeley

The license is foundational to MBI's ongoing development of a nanofluidics platform for the construction of integrated devices.
Advertisement